Virucidal activity of tiliacorinine, dioscorine, racemosol, and terrein against influenza A virus (H1N1), coronavirus 229E, SARS-CoV-2, and enterovirus 71

IF 4.7 3区医学 Q1 INFECTIOUS DISEASES

Journal of Infection and Public Health Pub Date : 2025-02-11 DOI:10.1016/j.jiph.2025.102699

Akanitt Jittmittraphap , Pornsawan Leaungwutiwong , Piyawan Meechokedee , Siriporn Chattanadee , Narin Thippornchai , Sanya Sureram , Chulabhorn Mahidol , Somsak Ruchirawat , Prasat Kittakoop

{"title":"Virucidal activity of tiliacorinine, dioscorine, racemosol, and terrein against influenza A virus (H1N1), coronavirus 229E, SARS-CoV-2, and enterovirus 71","authors":"Akanitt Jittmittraphap , Pornsawan Leaungwutiwong , Piyawan Meechokedee , Siriporn Chattanadee , Narin Thippornchai , Sanya Sureram , Chulabhorn Mahidol , Somsak Ruchirawat , Prasat Kittakoop","doi":"10.1016/j.jiph.2025.102699","DOIUrl":null,"url":null,"abstract":"<div><div>Emerging infectious diseases such as COVID-19 and Disease X, which was detected in the Democratic Republic of the Congo in early December 2024, underscore the importance of developing new virucidal, antiviral, and antimicrobial compounds. The virucidal activity of natural products, including tiliacorinine (1), dioscorine (2), racemosol (3), and terrein (4), against influenza A virus (H1N1), human coronavirus 229E (HCoV-229E), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and enterovirus 71 (EV71) were evaluated using the American Society for Testing and Materials E1053–20 method. Racemosol (3) from Bauhinia malabarica had the most potent virucidal activity against the H1N1, HCoV-229E, and SARS-CoV-2 viruses, followed by terrein (4), a metabolite of the fungus Aspergillus terreus. Racemosol (3) exhibited virucidal activity with a log reduction of 4 (99.99 % viral reduction) against H1N1, HCoV-229E, and SARS-CoV-2 at a concentration of 0.1250 mg/mL. The alkaloids tiliacorinine (1) from Tiliacora triandra and dioscorine (2) from Dioscorea hispida exhibited weaker virucidal activity than racemosol (3) and terrein (4). Compounds 1, 2, and 4 showed weak virucidal activity against the EV71 virus, while racemosol (3) displayed moderate activity with a log reduction of 3.813 at the concentration of 0.1250 mg/mL. This work underscores the importance of natural products as sources of virucidal agents, which may be useful for the future threats of emerging and re-emerging viral diseases.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"18 4","pages":"Article 102699"},"PeriodicalIF":4.7000,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection and Public Health","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1876034125000486","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}

引用次数: 0

Abstract

Emerging infectious diseases such as COVID-19 and Disease X, which was detected in the Democratic Republic of the Congo in early December 2024, underscore the importance of developing new virucidal, antiviral, and antimicrobial compounds. The virucidal activity of natural products, including tiliacorinine (1), dioscorine (2), racemosol (3), and terrein (4), against influenza A virus (H1N1), human coronavirus 229E (HCoV-229E), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and enterovirus 71 (EV71) were evaluated using the American Society for Testing and Materials E1053–20 method. Racemosol (3) from Bauhinia malabarica had the most potent virucidal activity against the H1N1, HCoV-229E, and SARS-CoV-2 viruses, followed by terrein (4), a metabolite of the fungus Aspergillus terreus. Racemosol (3) exhibited virucidal activity with a log reduction of 4 (99.99 % viral reduction) against H1N1, HCoV-229E, and SARS-CoV-2 at a concentration of 0.1250 mg/mL. The alkaloids tiliacorinine (1) from Tiliacora triandra and dioscorine (2) from Dioscorea hispida exhibited weaker virucidal activity than racemosol (3) and terrein (4). Compounds 1, 2, and 4 showed weak virucidal activity against the EV71 virus, while racemosol (3) displayed moderate activity with a log reduction of 3.813 at the concentration of 0.1250 mg/mL. This work underscores the importance of natural products as sources of virucidal agents, which may be useful for the future threats of emerging and re-emerging viral diseases.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Infection and Public Health PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH -INFECTIOUS DISEASES

CiteScore

13.10

自引率

1.50%

发文量

203

审稿时长

96 days

期刊介绍： The Journal of Infection and Public Health, first official journal of the Saudi Arabian Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences and the Saudi Association for Public Health, aims to be the foremost scientific, peer-reviewed journal encompassing infection prevention and control, microbiology, infectious diseases, public health and the application of healthcare epidemiology to the evaluation of health outcomes. The point of view of the journal is that infection and public health are closely intertwined and that advances in one area will have positive consequences on the other. The journal will be useful to all health professionals who are partners in the management of patients with communicable diseases, keeping them up to date. The journal is proud to have an international and diverse editorial board that will assist and facilitate the publication of articles that reflect a global view on infection control and public health, as well as emphasizing our focus on supporting the needs of public health practitioners. It is our aim to improve healthcare by reducing risk of infection and related adverse outcomes by critical review, selection, and dissemination of new and relevant information in the field of infection control, public health and infectious diseases in all healthcare settings and the community.